In this study, researchers isolated EVs from the blood (plasma) of PD patients of varying severity of disease ranging from mild to moderate stages and from control individuals and performed immunomagnetic reduction-based immunoassay to quantify the level of α-synuclein, tau, and Aβ1-42 proteins. This evidence concerns the gene SNCA and Parkinson disease.